|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Selling and marketing | |||||
| Research and development | |||||
| General and administrative | |||||
| Amortization of intangible assets | |||||
| Impairment of right-of-use and long-lived assets | |||||
| Restructuring | |||||
| Total expenses from operations | |||||
| Income (loss) from operations | |||||
| (Loss) gain from foreign currency transactions | |||||
| Loss on extinguishment of debt | |||||
| Interest expense, net | |||||
| Other income, net | |||||
| Loss before income taxes | |||||
| Income tax provision | |||||
| Net loss | |||||
| Other Comprehensive income (loss): | |||||
| Foreign currency cumulative translation adjustment | |||||
| Total comprehensive loss | |||||
| Convertible redeemable preferred stock dividends | |||||
| Preferred stockholders' deemed contribution | |||||
| Total net income (loss) available | |||||
| Net income (loss) available to common stockholders | |||||
| Net loss per common share : | |||||
| Basic (in usd per shares) | |||||
| Diluted (in usd per shares) | |||||
| Weighted-average number of shares used in per share calculation - Common Stock : | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...